SSRIs |
selective serotonin reuptake inhibitors |
SERT |
serotonin transporter |
FLX |
fluoxetine |
GABA |
gamma-Aminobutyric acid |
SNAP-25 |
synaptosomal nerve-associated protein 25 |
PKC |
protein kinase C |
VGCCs |
voltage-gated calcium channels |
NSF |
N-ethylmaleimide-sensitive factor |
SNARE |
soluble NSF attachment protein receptor |
MDD |
major depressive disorder |
HPA |
hypothalamic–pituitary axis |
ESC |
escitalopram |
5HTR |
5-hydroxytryptamine receptor |
BDNF |
brain-derived neurotrophic factor |
PFC |
prefrontal cortex |
HPC |
hippocampal complex |
SV |
synaptic vesicle |
Sph |
synaptophysin |
syt1-L ab |
synaptotagmin 1 luminal domain antibody |
VGLUT1 |
vesicular glutamate transporter 1 |
VGAT |
vesicular GABA transporter |
VAMP-2 |
Vesicle-associated membrane protein 2 |
AMPA |
α-amino-3-hydroxy-5-methyl-4- isoxazole-propanoic acid |
PSD95 |
postsynaptic density protein 95 |
BAPTA-AM |
1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester) |
PMA |
phorbol myristate acetate |
cal-C |
Calphostin C |
SNAP-25 |
Synaptosomal nerve-associated protein 25 |
DR |
dorsal raphe |
TPH2 |
Tryptophan hydroxylase 2 |
CSPα |
cysteine string protein α |
PD |
Parkinson’s disease |